Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,161,373
+$509,467 QoQ
Shares Held
1,802
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.09%
of 13F equity value
Holder Rank
#2,428
of 4,605 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026US Asset Management LLC holds $3,864,282 across 4 Drug Manufacturers - General names. LLY ranks #1 (55.9% of the industry book) .
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,161,373 | 1,802 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,651,906 | 1,796 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $1,939,797 | 1,805 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,386,371 | 1,817 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $1,421,083 | 1,823 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,523,803 | 1,845 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,429,744 | 1,852 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,693,917 | 1,912 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,828,867 | 2,020 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,629,048 | 2,094 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $928,008 | 1,592 | Shares | Sole | 2024-02-07 | |
| 2023-06-30 | $745,209 | 1,589 | Shares | Sole | 2023-08-22 | |
| 2023-03-31 | $566,643 | 1,650 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $605,465 | 1,655 | Shares | Sole | 2023-02-07 | |
| 2022-06-30 | $491,532 | 1,516 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $434,136 | 1,516 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $418,749 | 1,516 | Shares | Sole | 2022-03-30 | |
| 2021-09-30 | $350,271 | 1,516 | Shares | Sole | 2021-11-03 | |
| No filing history on record for this holder in this stock. | ||||||